Ethanol-Selected Staphylococcus Aureus Small Colony Variants by Peterson, Whitney
 Ethanol-Selected Staphylococcus aureus Small Colony Variants  
 
Whitney E. Peterson, Nathanial J. Torres, John E. Gustafson 
Honors Thesis 
May 2018  
Whitney Peterson 1 
 
Abstract 
Staphylococcus aureus has been shown to have the ability to display a small colony 
variant (SCV) phenotype, which is associated with persistent infections caused by acquisition of 
various degrees of resistance from antimicrobial therapy. S. aureus is targeted for death via 
antiseptic techniques, including the use of alcohols; little is known about the effects of these 
alcohols on the selective fitness of the species. This study displays the selection of ethanol-
reduced susceptibility (ERS) SCV mutants with inhibitory concentrations of ethanol. 
Additionally, these mutants showed changes in susceptibility to various antibiotics and 
antimicrobials. 
 
Introduction  
Staphylococcus aureus is a gram-positive pathogen and a leading cause of hospital-
acquired infections (1). Methicillin-resistant S. aureus (MRSA) are of particular concern, since 
these organisms typically display a multiple-antibiotic resistance phenotype and infections 
caused by these organisms therefore are difficult to treat (2, 3). S. aureus can also transition into 
the small colony variant (SCV) phenotype, which provides this organism an additional degree of 
protection from antimicrobials. In addition, SCVs are associated with persistent and reoccurring 
infections (8).  
 The use of alcohol-based hand rubs (ABHR) can decrease the transmission of S. aureus 
among individuals within healthcare settings (4). Alcohol functions as an antiseptic by 
denaturing bacterial membrane and protein structures (5, 6). Previously our laboratory published 
on the ethanol-induced stress response for S. aureus. In this study, MRSA strain LP9, isolated 
from a patient’s urine in El Paso, Texas, and hetero-vancomycin-intermediate S. aureus (hVISA) 
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and MRSA strain MM66, isolated from a patient’s sputum in Las Cruces, New Mexico, were 
exposed to 10% (v/v) ethanol resulting in the up-regulation of genes associated with protein 
quality control, oxidative stress, and toxin and anti-toxin systems while down-regulating genes 
involved with cell growth (transcription, translation, and nucleotide biosynthesis) (7, 10). This 
study also showed a down-regulation of genes associated with protein synthesis, osmotic stress, 
and lipid metabolism (7). A mutation in graS, which encodes a sensor histidine kinase, has been 
previously identified to be characteristic of the hVISA MM66 strain (13).  
 The objective of this project was to determine if ethanol can directly select for S. aureus 
ethanol reduced susceptibility (ERS) mutants. We now report that prolonged exposure to 
inhibitory concentrations of ethanol can select for S. aureus ERS mutants, regardless of genetic 
background, that also display the SCV phenotype. These SCV-ERS mutants also exhibited 
altered susceptibility to other antimicrobials.  
 
Methods 
Strains used in this study 
 S. aureus strains SH1000 (9), MRSA and VISA strain MM66 (10), and MRSA LP9 (11) were 
utilized in this study. MM66 was reported to have an increased level of susceptibility to ethanol, 
compared to LP9 (7).  
 
Isolation of ethanol mutants 
Single colonies of SH1000, MM66, and LP9 were used to inoculate 3 mL of Mueller Hinton 
broth (MHB) which was incubated overnight (37C, 200 rpm).  These overnight cultures were 
used to inoculate (2 % v/v inoculum) fresh MHB containing ethanol in capped growth flasks 
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which were allowed to grow (37C, 200 rpm) until visible growth appeared and the OD580nm was 
then recorded. All cultures were then passaged at each ethanol concentration (strain specific) 
investigated a total of five times.  A single loop full of culture was then take from the final 
ethanol containing culture and used to streak MHA plates in order to isolate single colonies. 
 
Gradient plates 
Briefly, 40 mL of molten MHA (55C) was poured onto petri plates (90 mm x 90 mm) elevated 
to 6 mm on one side and dried overnight. To create a second layer, 40 mL of MHA infused with 
the appropriate antimicrobial agent (Table II) and poured on top of the first layer and allowed to 
dry for 4 h. Diluted overnight MHB cultures  (OD580nm = 0.1) were then used to streak the 
gradients using a sterile cotton swab (X 3) and the gradient plates were incubated for 48 h (37C) 
before the distances grown in mm were measured (Table 2). 
 
Colony size measurements 
Overnight cultures, prepared as above, were serially diluted from 10-1 to 10-6.  One hundred 
microliters from each serial dilution was then spread onto MHA plates using a sterile metal rod 
and plates were grown overnight (37C). Colony diameters were then measured for each strain 
using a caliper.  
 
graS amplification and sequencing 
Genomic DNA was isolated using the Qiagen Genomic-tip 100/g columns (Qiagen, 
Germantown, MD) following the manufacturer's instruction. graS specific primers graS-F-GTG 
TCG TAT GAT TAT TAG AC and graS-R-GTC ACT TCC GAC ATG CGT TC were used to 
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PCR amplify the previously described graS mutation in MM66 (13). All PCR amplicons were 
then gel purified from a 1% agarose gel using the Monarch DNA Gel Extraction Kit (New 
England Biolabs, Ipswich, MA) and sent for sequencing.  
 
Results 
SH1000 was passaged from 9% to 12% v/v ethanol for 55 days before surviving colonies 
were picked (Table 1). MM66 took 36 days of passaging to complete its 10 passages from 10% 
to 11% v/v ethanol (Table 1).  A 2% inoculum from the last 11% ethanol MM66 culture failed to 
initiate growth in MHB containing 12% v/v ethanol after seven days of incubation.  LP9 took 29 
days to be passaged through 10% to 11% v/v ethanol, and an additional 16 days to complete 5 
passages at 12% ethanol (Table 1).  
Ethanol-selected mutants from all three strains all grew further on the ethanol gradients 
and produced smaller colonies (except SH125, Table 2) compared to their respective parent 
strains and therefore displayed an SCV-ERS phenotype (Table 2). 
The SH1000 SCV-ERS mutants grew to further distances on the isopropanol and 
vancomycin gradients but were unable to grow on a TTO gradient. SH121, SH123, and SH124 
showed reduced growth distances on triclosan gradient.  All the SH1000 SCV-ERS mutants, 
except SH122, showed reduced growth on oxacillin gradients (Table 2).  
All MM66 SCV-ERS mutants exhibited reduced growth distances on isopropanol, TTO, 
triclosan, and vancomycin gradients in comparison to MM66. However, all of the MM66 SCV-
ERS mutants grew further distances on oxacillin gradients compared to their parent strain (Table 
2). The amplification and sequencing of graS, characteristic of hVISA, indicated that all of the 
MM66 ERS mutants still harbored the graS mutation previously reported in MM66. 
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LP122, LP124, and LP125 grew further distances on the isopropanol gradient, while 
LP121 and LP123 grew shorter distances than LP9. LP122, LP123, and LP125 grew further 
distances on the TTO gradient, while LP121 and LP124 grew shorter distances on the same 
gradient. LP122, LP124, and LP125 displayed increased distances grown on the triclosan 
gradients in comparison to the parent strain, while LP121 and LP123 demonstrated reduced 
growth distances on the triclosan gradients. All LP9 SCV-ERS mutants also grew further 
distances on an oxacillin gradient, except for LP124. All LP9 mutants also grew further distances 
on the vancomycin gradient examined compared to LP9 (Table 2). 
 
Conclusions 
Prolonged exposure to inhibitory concentrations of ethanol selected for S. aureus SCV-
ERS mutants that also exhibited altered susceptibility to other cell wall targeting antimicrobial 
agents. Although MM66 mutants did not show visible growth in 12% ethanol, this is likely due 
to its lower MIC in comparison to LP9. Because MM66 still maintained the graS mutation, 
which has been shown to contribute to its hVISA phenotype, the reduced-susceptibility to 
vancomycin was likely due to other factors or transcriptional changes. For further studies, 
metabolomic and proteomic assays of the SCV-ERS mutants can be analyzed for mutations that 
correlate to other SCV S. aureus strains.  This study reinforces the necessity for all healthcare-
associated workers to fully comply with ABHR protocols for hand sanitization and provides 
incentive to investigate ethanol susceptibilities of S. aureus clinical isolates. 
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Table 1. Ethanol selection in-vitro 
   Ethanol passage (number of days – OD580)       Total days 
               of selection 
   1  2  3  4  5 
Strain 
 
SH1000 
 
9%   4 - 2.250 2 - 1.052 1 - 2.672 1 - 1.494 1 - 1.183   9 
 
10%   3 - 1.454 2 - 2.137 1 - 1.127 1 - 1.127 1 - 1.398   17 
 
11%   4 - 1.476 5 - 1.099 2 - 1.166 3 - 1.304 3 - 1.280   34 
 
12%   5 - 0.525 4 - 1.125 5 - 0.771 4 - 1.110 3 - 1.250   55 
 
MM66 
 
10%   4 - 1.197 4 - 1.079 3 - 1.016 3 - 1.048 2 - 1.048   16 
 
11%   5 - 0.527 5 - 1.204 3 - 1.109 5 - 1.085 2 - 1.067   36 
 
LP9 
 
10%   3 - 1.180 5 - 0.232 2 - 1.528 2 - 1.698 1 - 1.218   13 
 
11%   5 - 0.599 4 - 1.402 2 - 1.069 3 - 1.343 2 - 1.343   29 
 
12%   3 - 1.108 5 - 1.044 3 - 1.375 2 - 1.304 3 - 1.459   45 
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